FDA inspection
Janssen Research & Development: FDA inspection ending Jun 14, 2024
FDA inspection 1245603 · No Action Indicated (NAI) · Spring House, PA
Key facts
| Inspection ID | 1245603 |
|---|---|
| Firm | Janssen Research & Development |
| FEI number | 3003519048 |
| Address | 1400 Mckean Rd |
| City | Spring House |
| State | PA |
| ZIP | 19477 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Jun 14, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data